Natacha Bolaños and Giuseppe Curigliano discuss EU legislation on HTA – ECO

European Cancer Organisation (ECO) shared on LinkedIn:

“Are we ready for Joint Clinical Assessments?

On 8 October, 15:00-17:30 CEST, Natacha Bolaños and Giuseppe Curigliano are leading a roundtable to discuss EU legislation on Health Technology Assessment (HTA) due to come into force in January 2025.

Join us!”

Source: European Cancer Organisation/LinkedIn

Giuseppe Curigliano, MD, PhD, is the Director of  the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.